Drugs R D. 2005;6(1):11-9.
Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
Nutr Rev. 2003 Nov;61(11):376-83.
Role of policosanols in the prevention and treatment of cardiovascular disease.
Int J Clin Pharmacol Res. 2002;22(3-4):89-99.
Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Med Hypotheses. 2002 Sep;59(3):268-79.
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
Drugs R D. 2002;3(3):159-72.
Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Am Heart J. 2002 Feb;143(2):356-65.
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M186-92.
Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
Angiology. 2001 Feb;52(2):115-25.
A long-term study of policosanol in the treatment of intermittent claudication.
Br J Clin Pharmacol. 2000 Sep;50(3):255-62.
Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.
Int J Clin Pharmacol Res. 1999;19(4):117-27.
Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus
Int J Clin Pharmacol Res. 1999;19(4):105-16.
Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Braz J Med Biol Res. 2000 Jul;33(7):835-40.
Protective effect of policosanol on atherosclerotic lesions in rabbits with
exogenous hypercholesterolemia.
Int J Tissue React. 1999;21(3):85-92.
A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
Rev Med Chil. 1999 Mar;127(3):286-94.
Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia.
Int J Tissue React. 1998;20(4):119-24.
Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Int J Clin Pharmacol Ther. 1998 Sep;36(9):469-73.
Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients.
Prostaglandins Leukot Essent Fatty Acids. 1998 Jan;58(1):61-4.
Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers.
Int J Clin Pharmacol Res. 1995;15(4):159-65.
A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
Biol Res. 1994;27(3-4):199-203.
Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts.
Int J Clin Pharmacol Res. 1994;14(1):27-33.
Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
|
留言反馈 
联系我们 
网站地图 
